Payment overview · 2025
General Payments
$102.02
1 reported records · 1 companies
Healthcare provider profile · identity verified
Harpreet Singh, M.D.
Allopathic & Osteopathic Physicians|General Practice · JACKSONVILLE, FL · NPI 1205944071
Verified facts
What the public records show
CMS Open Payments records show Harpreet Singh, M.D. received $102.02 in general payments during 2025 across 1 reported records.
Gilead Sciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Gilead Sciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Biktarvy as an associated drug or biological on 8065 records involving 2759 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Biktarvy by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | Unresolved — no canonical attribution shown | $102.02 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $102.02 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Epclusa Normalized: epclusa |
Drug | Gilead Sciences, Inc. | $102.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. Exact reporting entity; no affiliate inference |
2025 | Biktarvy open payments reported associated product |
CMS Open Payments — General Payments 8065 supporting records · 2759 recipient NPIs · example record 1234350766 |
Biktarvy · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 657 | 132 |
| Eliquis | Apixaban | 489 | 69 |
| Amlodipine Besylate | Amlodipine Besylate | 380 | 75 |
| Gabapentin | Gabapentin | 359 | 67 |
| Metoprolol Tartrate | Metoprolol Tartrate | 338 | 81 |
| Furosemide | Furosemide | 294 | 76 |
| Trazodone Hcl | Trazodone Hcl | 289 | 67 |
| Clopidogrel | Clopidogrel Bisulfate | 279 | 49 |
| Levothyroxine Sodium | Levothyroxine Sodium | 278 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 271 | 70 |
| Donepezil Hcl | Donepezil Hcl | 265 | 50 |
| Potassium Chloride | Potassium Chloride | 260 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 259 | 46 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 254 | 28 |
| Levetiracetam | Levetiracetam | 247 | 37 |
| Mirtazapine | Mirtazapine | 212 | 45 |
| Lisinopril | Lisinopril | 184 | 38 |
| Sertraline Hcl | Sertraline Hcl | 180 | 38 |
| Divalproex Sodium | Divalproex Sodium | 177 | 28 |
| Nifedipine Er | Nifedipine | 173 | 39 |
| Lactulose | Lactulose | 158 | 30 |
| Losartan Potassium | Losartan Potassium | 157 | 44 |
| Carvedilol | Carvedilol | 153 | 35 |
| Buspirone Hcl | Buspirone Hcl | 135 | 29 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 132 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 126 | 24 |
| Latanoprost | Latanoprost | 122 | 21 |
| Memantine Hcl | Memantine Hcl | 122 | 22 |
| Januvia | Sitagliptin Phosphate | 121 | 11 |
| Simvastatin | Simvastatin | 119 | 16 |
| Tramadol Hcl | Tramadol Hcl | 107 | 15 |
| Baclofen | Baclofen | 101 | 19 |
| Metformin Hcl | Metformin Hcl | 101 | 18 |
| Metoprolol Succinate | Metoprolol Succinate | 101 | 31 |
| Novolog Flexpen | Insulin Aspart | 101 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 100 | 31 |
| Ondansetron Hcl | Ondansetron Hcl | 97 | 40 |
| Montelukast Sodium | Montelukast Sodium | 94 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 87 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 85 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 82 | 17 |
| Famotidine | Famotidine | 76 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 73 | 21 |
| Spironolactone | Spironolactone | 73 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 72 | suppressed |
| Allopurinol | Allopurinol | 69 | 14 |
| Insulin Aspart Flexpen | Insulin Aspart | 69 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 69 | 11 |
| Olanzapine | Olanzapine | 68 | 13 |
| Brimonidine Tartrate | Brimonidine Tartrate | 64 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | suppressed |
| Prednisone | Prednisone | 64 | 29 |
| Amiodarone Hcl | Amiodarone Hcl | 62 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 62 | 20 |
| Levemir Flexpen | Insulin Detemir | 61 | 13 |
| Risperidone | Risperidone | 59 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 58 | 22 |
| Megestrol Acetate | Megestrol Acetate | 57 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 53 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 53 | suppressed |
| Omeprazole | Omeprazole | 52 | 15 |
| Brilinta | Ticagrelor | 51 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 51 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 49 | 19 |
| Midodrine Hcl | Midodrine Hcl | 49 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | suppressed |
| Torsemide | Torsemide | 48 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 46 | 32 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 45 | 21 |
| Diclofenac Sodium | Diclofenac Sodium | 44 | 12 |
| Ibuprofen | Ibuprofen | 44 | 12 |
| Myrbetriq | Mirabegron | 44 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 43 | suppressed |
| Lamotrigine | Lamotrigine | 43 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 42 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 40 | suppressed |
| Bumetanide | Bumetanide | 39 | 13 |
| Alprazolam | Alprazolam | 37 | suppressed |
| Nystatin | Nystatin | 37 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 35 | suppressed |
| Finasteride | Finasteride | 35 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 34 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 34 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 33 | 11 |
| Jardiance | Empagliflozin | 31 | suppressed |
| Chlorthalidone | Chlorthalidone | 30 | suppressed |
| Meloxicam | Meloxicam | 30 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 30 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 29 | 18 |
| Cholestyramine | Cholestyramine (With Sugar) | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Primidone | Primidone | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | suppressed |
| Calcitriol | Calcitriol | 27 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 27 | suppressed |
| Xarelto | Rivaroxaban | 27 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 25 | suppressed |
| Amantadine | Amantadine Hcl | 25 | suppressed |
| Ketoconazole | Ketoconazole | 25 | 12 |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 24 | suppressed |
| Clonidine | Clonidine | 22 | suppressed |
| Clozapine | Clozapine | 22 | suppressed |
| Mupirocin | Mupirocin | 22 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Carbamazepine Er | Carbamazepine | 21 | suppressed |
| Cephalexin | Cephalexin | 21 | 17 |
| Methotrexate | Methotrexate Sodium | 21 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 20 | suppressed |
| Tradjenta | Linagliptin | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 19 | suppressed |
| Levemir | Insulin Detemir | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Budesonide | Budesonide | 17 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 17 | 13 |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Atenolol | Atenolol | 16 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 16 | suppressed |
| Dextrose 5%-0.9% Nacl | Dextrose 5 % And 0.9 % Nacl | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | 11 |
| Nitroglycerin Patch | Nitroglycerin | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Alphagan P | Brimonidine Tartrate | 15 | suppressed |
| Clonazepam | Clonazepam | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 15 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 14 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 14 | suppressed |
| Movantik | Naloxegol Oxalate | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Daptomycin | Daptomycin | 13 | suppressed |
| Dexamethasone | Dexamethasone | 13 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 13 | 11 |
| Difluprednate | Difluprednate | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Felbamate | Felbamate | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Ethosuximide | Ethosuximide | 11 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $102.02 · 1 records | Gilead Sciences, Inc. | Epclusa | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Gilead Sciences, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error